Effect of sertraline as an add-on therapy in T2DM patients with comorbid depression: An open label randomized controlled trial
Objectives: To study the effect of sertraline on depression in type 2 diabetes mellitus (T2DM) patients with comorbid depression. Materials and Methods: An open label randomized control study. Patients with T2DM and moderate to severe depression were randomized to sertraline or control therapy for s...
Main Authors: | Padala R Kumar, Anindita Chatterjee, Jayanti P Behera, Sudhiranjan Patnaik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=3;spage=357;epage=362;aulast=Kumar |
Similar Items
-
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
by: Maria S. Simon, et al.
Published: (2021-09-01) -
Comparing the Efficacy of Fluvoxamine and Sertraline in Treating Major Depressive Disorder (MDD)
by: Seyed-Saeid Hasani-Tabatabaei, et al.
Published: (2013-12-01) -
An observational study to evaluate the awareness of drug treatment, prescription pattern, adverse drug reactions, and adherence in patients of major depressive disorder
by: Urwashi Indrakumar Parmar, et al.
Published: (2024-04-01) -
Assessing the beliefs about antidepressant medication and adherence to therapy in patients with major depressive disorders.
by: Samia Perwaiz Khan, et al.
Published: (2021-06-01) -
Efficacy of a glucose meter connected to a mobile app on glycemic control and adherence to self-care tasks in patients with T1DM and LADA: a parallel-group, open-label, clinical treatment trial
by: Felipe Martins de Oliveira, et al.
Published: (2021-03-01)